Clinical Trial Update: A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of intraventricular liposomal cytarabine (DepoCyt) for recurrent glioblastoma was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Brain Tumor
• Glioblastoma
• Glioma

Drugs mentioned

• DepoCyt (liposomal cytarabine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Glioblastoma Multiforme, Glioma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-02-12